Tourbillon Capital Partners, L.P.

Add to watchlist

$2.59 Billion is the total value of Tourbillon Capital Partners, L.P.'s 74 reported holdings in Q2 2018. The portfolio turnover from Q1 2018 to Q2 2018 was 54.5% .

All

			Value		Shares		↓ Weighting
	Sell	SPDR S&P 500 ETF TRput	$325,536,000	-17.5%	1,200,000	-20.0%	12.59%	-19.6%
WP	Sell	WORLDPAY INCcl a	$65,609,000	-22.9%	802,262	-22.4%	2.54%	-24.8%
LPLA	Sell	LPL FINL HLDGS INC	$57,618,000	-5.7%	879,133	-12.1%	2.23%	-8.0%
ADSK	Sell	AUTODESK INC	$56,369,000	-42.8%	430,000	-45.3%	2.18%	-44.3%
HUM	Sell	HUMANA INC	$54,492,000	-15.5%	183,085	-23.7%	2.11%	-17.6%
SPB	Sell	SPECTRUM BRANDS HLDGS INC	$53,142,000	-66.7%	651,088	-57.7%	2.06%	-67.5%
ALXN	Sell	ALEXION PHARMACEUTICALS INC	$43,838,000	+9.9%	353,106	-1.3%	1.70%	+7.1%
AMTD	Sell	TD AMERITRADE HLDG CORP	$39,869,000	-30.3%	727,940	-24.6%	1.54%	-32.1%
BABA	Sell	ALIBABA GROUP HLDG LTDsponsored ads	$39,587,000	-39.8%	213,372	-40.4%	1.53%	-41.3%
V	Sell	VISA INC	$38,401,000	-30.2%	289,930	-37.0%	1.48%	-32.0%
FLT	Sell	FLEETCOR TECHNOLOGIES INC	$36,136,000	-63.0%	171,543	-64.4%	1.40%	-63.9%
FOLD	Sell	AMICUS THERAPEUTICS INC	$32,754,000	-18.7%	2,096,930	-21.7%	1.27%	-20.7%
SYK	Sell	STRYKER CORP	$31,695,000	-17.9%	187,700	-21.8%	1.23%	-20.0%
BPOP	Sell	POPULAR INC	$29,254,000	-17.1%	647,066	-23.7%	1.13%	-19.2%
ANTM	Sell	ANTHEM INC	$26,447,000	+0.3%	111,106	-7.4%	1.02%	-2.2%
EVHC	Sell	ENVISION HEALTHCARE CORP	$25,746,000	-47.6%	585,001	-54.2%	1.00%	-48.9%
FB	Sell	FACEBOOK INCcl a	$25,531,000	-56.8%	131,386	-64.5%	0.99%	-57.9%
	Sell	ALEXION PHARMACEUTICALS INCcall	$24,830,000	-40.6%	200,000	-46.7%	0.96%	-42.1%
STKL	Sell	SUNOPTA INC	$21,647,000	-5.2%	2,577,028	-19.8%	0.84%	-7.5%
FBP	Sell	FIRST BANCORP P R	$17,807,000	-2.5%	2,327,679	-23.3%	0.69%	-5.0%
	Sell	FACEBOOK INCcall	$14,846,000	-7.1%	76,400	-23.6%	0.57%	-9.5%
GPP	Sell	GREEN PLAINS PARTNERS LP	$13,721,000	-18.0%	800,076	-16.8%	0.53%	-20.0%
CWH	Sell	CAMPING WORLD HLDGS INCcl a	$10,913,000	-51.3%	436,867	-37.2%	0.42%	-52.6%
NVRO	Sell	NEVRO CORP	$7,008,000	-72.6%	87,759	-70.2%	0.27%	-73.2%
KRYS	Sell	KRYSTAL BIOTECH INC	$3,052,000	+19.9%	205,236	-18.7%	0.12%	+16.8%
	Exit	CRISPR THERAPEUTICS AGput	$0	–	-35,000	-100.0%	-0.06%	–
	Exit	EDITAS MEDICINE INCput	$0	–	-50,000	-100.0%	-0.07%	–
PIRS	Exit	PIERIS PHARMACEUTICALS INC	$0	–	-295,100	-100.0%	-0.08%	–
NITE	Exit	NIGHTSTAR THERAPEUTICS PLCadr	$0	–	-170,952	-100.0%	-0.10%	–
	Exit	LOXO ONCOLOGY INCput	$0	–	-25,000	-100.0%	-0.11%	–
GIS	Exit	GENERAL MLS INC	$0	–	-75,000	-100.0%	-0.13%	–
IQ	Exit	IQIYI INCsponsored ads	$0	–	-250,000	-100.0%	-0.15%	–
	Exit	NEKTAR THERAPEUTICSput	$0	–	-90,000	-100.0%	-0.38%	–
	Exit	SERVICE CORP INTLcall	$0	–	-391,600	-100.0%	-0.59%	–
	Exit	SAREPTA THERAPEUTICS INCcall	$0	–	-200,000	-100.0%	-0.59%	–
	Exit	FACEBOOK INCput	$0	–	-100,000	-100.0%	-0.63%	–
	Exit	CARMAX INCcall	$0	–	-300,000	-100.0%	-0.74%	–
	Exit	AMICUS THERAPEUTICS INCcall	$0	–	-1,500,000	-100.0%	-0.90%	–
	Exit	AMICUS THERAPEUTICS INCput	$0	–	-1,500,000	-100.0%	-0.90%	–
	Exit	COMCAST CORP NEWcall	$0	–	-750,000	-100.0%	-1.02%	–
LDOS	Exit	LEIDOS HLDGS INC	$0	–	-402,177	-100.0%	-1.04%	–
KMX	Exit	CARMAX INC	$0	–	-451,536	-100.0%	-1.11%	–
	Exit	SPECTRUM BRANDS HLDGS INCcall	$0	–	-300,000	-100.0%	-1.23%	–
BIIB	Exit	BIOGEN INC	$0	–	-125,801	-100.0%	-1.37%	–
	Exit	ARCONIC INCcall	$0	–	-1,600,000	-100.0%	-1.46%	–
	Exit	GW PHARMACEUTICALS PLCcall	$0	–	-350,000	-100.0%	-1.56%	–
	Exit	GW PHARMACEUTICALS PLCput	$0	–	-350,000	-100.0%	-1.56%	–
	Exit	ALEXION PHARMACEUTICALS INCput	$0	–	-375,000	-100.0%	-1.66%	–
	Exit	MERCK & CO INCcall	$0	–	-797,500	-100.0%	-1.72%	–
LOW	Exit	LOWES COS INC	$0	–	-503,000	-100.0%	-1.75%	–
MGM	Exit	MGM RESORTS INTERNATIONAL	$0	–	-1,510,000	-100.0%	-2.10%	–
SRPT	Exit	SAREPTA THERAPEUTICS INC	$0	–	-758,413	-100.0%	-2.23%	–
AVGO	Exit	BROADCOM LTD	$0	–	-299,400	-100.0%	-2.80%	–
L100PS	Exit	ARCONIC INC	$0	–	-3,104,561	-100.0%	-2.84%	–
SCI	Exit	SERVICE CORP INTL	$0	–	-2,081,085	-100.0%	-3.12%	–

Original filings

The following EDGAR filing(s) were analyzed to create this report:

View 13F-HR filed 2018-08-14

Signatures

The EDGAR filing(s) were signed by:

Brian A. Kessler — CFO

Top long-term holdings

Name	Quarters owned	Latest quarter owned	Max weighting
SUNOPTA INC	20	Q4 2018	100.0%
DISH NETWORK CORP	17	Q4 2017	6.8%
SPDR S&P 500 ETF TR	16	Q4 2017	23.2%
SPECTRUM BRANDS HLDGS INC	16	Q2 2018	11.7%
CTRIP COM INTL LYD	15	Q2 2017	4.6%
MACQUARIE INFRASTRUCTURE COR	15	Q4 2017	1.3%
GREEN PLAINS PARTNERS LP	14	Q3 2018	1.2%
EXPEDIA INC DEL	13	Q4 2016	8.3%
GREEN PLAINS RENEWABLE ENERG	13	Q3 2017	2.1%
POST HLDGS INC	12	Q4 2017	7.4%

View Tourbillon Capital Partners, L.P.'s complete holdings history.

Latest significant ownerships (13-D/G)

Tourbillon Capital Partners, L.P. Q2 2018 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
	Filed	Shares	Percentage
Spectrum Brands Legacy, Inc.^{Sold out}	February 14, 2019	0	0.0%
Green Plains Inc.^{Sold out}	February 14, 2018	0	0.0%
Post Holdings, Inc.	February 14, 2018	125,185	-
Radius Health, Inc.	February 14, 2018	500,000	1.1%
Sarepta Therapeutics, Inc.	February 14, 2018	2,027,225	3.1%
SunOpta Inc.	December 18, 2017	4,163,662	4.8%
Green Plains Partners LP	December 15, 2017	1,153,423	7.2%
American Homes 4 Rent	February 14, 2017	429,000	0.2%
CONNS INC^{Sold out}	February 14, 2017	0	0.0%
Dipexium Pharmaceuticals, Inc.^{Sold out}	February 14, 2017	0	0.0%

View Tourbillon Capital Partners, L.P.'s complete significant-ownership history.

Latest filings

Type	Filed
13F-HR	2019-02-14
SC 13G/A	2019-02-14
13F-HR	2018-11-14
13F-HR	2018-08-14
13F-HR	2018-05-15
13F-HR	2018-02-14
SC 13G/A	2018-02-14
SC 13G/A	2018-02-14
SC 13G/A	2018-02-14
SC 13G/A	2018-02-14

View Tourbillon Capital Partners, L.P.'s complete filings history.

All filings

View complete filings history.

Compare quarters

Export Tourbillon Capital Partners, L.P.'s holdings